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Malignant ectomesenchymoma (MEM) which is derived from the remnants of migratory neural crest
cells (ectomesenchyme) is a rare and rapidly progressing tumor consisting of neuroectodermal and
mesenchymal neoplastic elements. This tumor occurs mostly in children and adolescents, but rarely in
adults. We report a 34-year-old male with left paratesticular malignant ectomesenchymoma who
received radical orchiectomy and was followed by post-operative ﬂare-up of lung metastasis within
2 weeks. We present the overall treatment strategies for this extremely rare tumor and related ﬁndings.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Malignant ectomesenchymoma (MEM) which is derived from
the remnants of migratory neural crest cells (ectomesenchyme) is a
rare and rapidly progressing tumor consisting of neuroectodermal
and mesenchymal neoplastic elements.1 This tumor has been re-
ported to occur mostly in children and adolescents, with its origin
from brain, face and neck, abdomen, retroperitoneal space, pelvic
cavity, perineum, scrotum, and limbs.1 To date, only seven scrotal
malignant ectomesenchymomas have been reported. Here we
report the eighth case of paratesticular malignant ectomesenchy-
moma and emphasize its occurrence in an adult with post-
operative ﬂare-up of lung metastasis.
Case presentation
A 34-year-old male visited our out-patient clinic with the
painless left testicular mass for 1 month. Prior to this, he did not
have any history of scrotal trauma, scrotal surgery, infection, and
cryptorchidism. Physical examination revealed a swollen left
scrotum with a painless solid mass. Ultrasound examination
showed a heterogenous solidmass of 75 40mm in size. The levels
of lactic dehydrogenase (120 U/mL), alpha-fetoprotein (0.92 ng/
mL), and beta human chorionic gonadotropin (0.19 mIU/mL) wereTaipei Medical University,
he District, New Taipei City
x: þ886 2 2249 0088x8760.
Inc. This is an open access article uall within normal limits. The contrast-enhanced computed
tomography demonstrated the presence of a heterogenous tumor
in the left scrotum area (Fig. 1). Chest x-ray showed no evidence of
lung tumor. A radical orchiectomy was performed. After an un-
eventful post-operative period, the patient was discharged from
hospital. Over a two-week post-operative follow-up, multiple lung
tumors were found on chest x-ray. CT-guided lung mass biopsy was
performed. The pathology revealed a metastatic malignant ecto-
mesenchymoma that was compatible with the previous scrotum
lesion. He was referred to the medical oncology department to
receive further chemotherapy treatment.
Histopathological examination showed a yellowish white and
elastic tumor measuring 7.5  4.0  3.6 cm in size was found to be
located in the para-testicular soft tissue. The testis was not
involved. The tumor had two components connecting with each
other. The main component was composed of an alternating area
of hypercellularity and myxoid tissues. The compact hypercellular
area was composed of hyperchromatic cells with moderately
pleomorphic nuclei and scattered multinucleated giant tumor
cells. The myxoid area exhibited scattered spindle cells in mucoid
stroma with increased mitotic activity. The other components of
the tumor were composed of spindle cells with wavy nuclei ar-
ranged in loose, irregularly oriented bundles and scattered gan-
glion cells. Immunohistochemical staining showed the main
component of the tumor cells were positive for desmin, myogenin,
and myoglobin, and negative for SMA, S100, cytokeratin, EMA,
synaptophysin and CD34. Thus, anaplastic embryonal rhabdo-
myosarcoma was considered. The other components of the tumor
showed that the spindle cells were positive for S100, and negative
for desmin, myoglobulin, myogenin and SMA. The ganglion cellsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Pelvic CT scan showing heterogenous tumor in left scrotum (arrow) and left
testis (arrowhead).
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consideration. Consequently, a malignant ectomesenchymoma
was more likely based on the combined pathologic ﬁndings
mentioned above (Fig. 2).Discussion
Malignant ectomesenchymomas (MEMs) are extremely rare
tumors with about 50 cases, mostly involving children and infants,
having been reported to date. Characterized by merged features of
neuroectodermal and mesenchymal components,2 the most com-
mon neuroectodermal component is ganglioneuroblastoma, or
neuroblastoma,2 whereas the most common mesenchymal com-
ponents are embryonal rhabdomyosarcoma or other malignant
mesenchymal components.3 Some MEMs have been diagnosed as
pure rhabdomyosarcoma in the beginning.4Figure 2. Histological features of MEM. A) The rhabdomyosacroma component showed al
pleomorphic nuclei, and scattered multinucleated tumor cells (H&E 200). B) The ganglione
oriented bundles with scattered ganglion cells (H&E 200). C) The rhabdomyosacroma com
D) The ganglioneuroma component was positive for S100 (Immunohistochemical stain forOnly seven cases of MEM involving the scrotum region have
been noted (Table 1)3,11 and six of these were localized tumors
followed by surgical resection and post-operative chemotherapy or
radiotherapy.3,11 The prevalence age for these seven cases ranged
from 2 months to 20 year old and mostly involved infants and
children below the age of three. Our patient would appear to be the
eldest patient observed after a review of the related literature.
MEMs usually spread en route circulation to lung or bone, or en
route through the lymphatic system to retroperitoneal lymph
nodes.12 To the best of our knowledge, our case is the ﬁrst with the
characteristic of ﬂare-up of lung metastatic lesions after surgical
excision of the primary tumor.
Due to the rarity of these cancers, the standard therapeutic
strategy that should be employed is ambiguous. To date, the most
favorable therapeutic strategy for scrotal ectomesenchymoma is
surgical resection to be as complete as possible and most of cases
received complete tumor resection at diagnosis. Anatomically, it
would be easier to perform complete resection of scrotal MEMs
than other MEMs which originate from other organs and the out-
comes certainly would be better. According to certain reports,
chemotherapy also plays an important role in the treatment of
MEMs.2 The fact that most mesenchymal components of ectome-
senchymomas are rhabdomyosarcoma actually facilitates the
selection of various chemotherapeutic agents by referring to the
therapies for rhabdomyosarcoma.
A poor prognosis was speculated in our case based on the
prognosis-affected factors of MEM. Two considerations affect the
prognosis of MEM predominately. The ﬁrst point is the ﬂare-up of
lung metastasis post radical orchiectomy, which could be consid-
ered as the crucial indicator of prognosis. The second point is the
age of the patient. Age factor may be also relate to survival, asternating cellular and myxoid area, hyperchromatic cells associated with moderately
uroma component showed spindle cells with wavy nuclei arranged in loose irregularly
ponent was positive for Myogenin (Immunohistochemical stain for Myogenin, 100).
S100 100).
Table 1
Literature review of scrotal MEM
Reference Year Age Origin site Histology Treatment Follow-up
Cozzuto et al.5 1982 3 y/o Paratesticular Ganglion cells, Rhabdomyosarcoma S þ C No recurrence after 3 years
Kodet et al.6 1986 7 m/o Paratesticular Ganglioneuroma, Rhabdomyosarcoma S þ R þ C No recurrence after 12 years
Kasantikul et al.7 1987 20 y/o Scrotum Ganglioneuroma, Rhabdomyosarcoma ND ND
Kilpatrick8 1994 10 m/o Scrotum Mature ganglion cell, Rhabdomyosarcoma ND Alive 9.5 years
Mouton et al.9 1996 7 m/o Scrotum Ganglion cells, Rhabdomyoblast, miscellaneous cells S þ C No recurrence 7 months
Mouton et al.9 1996 2 m/o Scrotum Neural components, miscellaneous cells C þ S No recurrence 32 months
Edwards et al.10 1999 13 y/o Paratesticular T: Rhabodomyosarcoma, RP: Ganglion cell þ Rhabdomyosarcoma S þ R þ C RP Meta at 2 years
Present 34 y/o Paratesticular þ Lung meta Embryonal rhabdomyosarcoma Ganglioneuroma S þ C Alive 6 months
C, Chemotherapy; Meta, Metastasis; ND, No data available; R, Radiotherapy; RP, Retroperitoneum; S, Surgery; T, Testis.
W.-T. Kao et al. / Urology Case Reports 3 (2015) 164e166166patients at an age higher than 10 years old could show a worse
prognosis in cases of rhabdomyosarcoma,8 and the prognosis of
MEM is known to be worse than rhabdomyosarcoma.4
Conclusion
We report a rare case of paratesticular MEMswhich shows ﬂare-
up lung metastasis after radical orchiectomy.
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